About Virios
Leadership
Board of Directors
Scientific Advisors
Corporate Presentation
Target Diseases
Fibromyalgia
Long Covid
Blog
Pipeline
Pipeline
Presentations and Publications
Investors
News
Contact
All SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
Events & Presentations
Events
Presentations
Shareholder Letters
Meeting
Governance
Overview
Leadership
Board of Directors
Board Committees
Governance Documents
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Financial & Stock Info
Overview
Quote
Charts
Historical Data
Analyst Coverage
Resources
Overview
IR Contacts
FAQ
Email Alerts
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-Q
3
4
4/A
424B4
5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRSLTR
EFFECT
FWP
PRE 14A
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2023
2022
2021
2020
Date
Form
Description
PDF
XBRL
Pages
07/24/20
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
174
Previous
1…
9
10
11
12
13
14
15
16
17
18
Email Alerts
Contacts
RSS News Feed